Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
Mi | OneMedNet Corporation: OneMedNet and Protege Partner to Advance the Future of AI-Driven Healthcare with Real-Time, Multimodal Data | 1 | GlobeNewswire (USA) | ||
15.04. | OneMedNet Corp - 8-K, Current Report | 1 | SEC Filings | ||
15.04. | OneMedNet Corp - 10-K, Annual Report | 1 | SEC Filings | ||
01.04. | OneMedNet Corp - NT 10-K, Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 | 2 | SEC Filings | ||
14.03. | OneMedNet Corp - 8-K, Current Report | 1 | SEC Filings | ||
ONEMEDNET Aktie jetzt für 0€ handeln | |||||
10.03. | OneMedNet Corporation: 31 Million Patient Journeys, One Mission | 2 | GlobeNewswire (USA) | ||
03.03. | OneMedNet Corporation: Dr. Kenneth Alleyne Joins OneMedNet Board of Directors | 2 | GlobeNewswire (USA) | ||
03.03. | OneMedNet Corp - 8-K, Current Report | - | SEC Filings | ||
10.02. | OneMedNet Corp - S-8, Securities to be offered to employees in employee benefit plans | 1 | SEC Filings | ||
06.02. | OneMedNet Corp - 8-K, Current Report | - | SEC Filings | ||
03.02. | OneMedNet Corp - S-1/A, General form for registration of securities | - | SEC Filings | ||
13.01. | OneMedNet regains compliance with Nasdaq | 2 | Seeking Alpha | ||
13.01. | OneMedNet Corporation: OneMedNet Regains Compliance with NASDAQ Listing Requirements | 159 | GlobeNewswire (Europe) | MINNEAPOLIS, Jan. 13, 2025 (GLOBE NEWSWIRE) -- OneMedNet Corporation (Nasdaq: ONMD) ("OneMedNet" or the "Company"), a global provider of clinical imaging innovation and curator of regulatory-grade... ► Artikel lesen | |
10.01. | OneMedNet Corporation regains Nasdaq compliance | 1 | Seeking Alpha | ||
10.01. | OneMedNet Corporation: OneMedNet Regains Compliance with NASDAQ Minimum Bid Price Requirements | 198 | GlobeNewswire (Europe) | MINNEAPOLIS, Jan. 10, 2025 (GLOBE NEWSWIRE) -- OneMedNet Corporation (Nasdaq: ONMD) ("OneMedNet" or the "Company"), a global provider of clinical imaging innovation and curator of regulatory-grade... ► Artikel lesen | |
30.12.24 | OneMedNet erfüllt Nasdaq-Compliance mit Berichtseinreichungen | 6 | Investing.com Deutsch | ||
30.12.24 | OneMedNet achieves Nasdaq compliance with report filings | 3 | Investing.com | ||
30.12.24 | OneMedNet Corporation: OneMedNet Regains Compliance with NASDAQ Periodic Filing Requirements | 280 | GlobeNewswire (Europe) | MINNEAPOLIS, Dec. 30, 2024 (GLOBE NEWSWIRE) -- OneMedNet Corporation (Nasdaq: ONMD) ("OneMedNet" or the "Company"), a global provider of clinical imaging innovation and curator of regulatory-grade... ► Artikel lesen | |
30.12.24 | OneMedNet Corp - 8-K, Current Report | 2 | SEC Filings | ||
20.12.24 | OneMedNet Corp - 8-K, Current Report | - | SEC Filings |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
NUGEN MEDICAL DEVICES | 0,059 | +8,89 % | Osterlektüre: Die 13.000%-Chance für ihr Depot! | ||
HEALWELL AI | 0,963 | +0,89 % | HEALWELL gibt strategische Änderungen in Führungsteam bekannt, um die nächste Phase der Integration, des Wachstums und der Schaffung von Mehrwert für die Aktionäre voranzutreiben | TORONTO, ON, 23. April 2025 / IRW-Press / HEALWELL AI Inc. ("HEALWELL" oder das "Unternehmen") (TSX: AIDX, OTCQX: HWAIF), ein Unternehmen für künstliche Intelligenz im Gesundheitswesen, das auf... ► Artikel lesen | |
SPINEWAY | 0,111 | 0,00 % | Spineway: First-quarter 2025 revenue of €2.8 million | Press release Ecully, April 16, 2025 - 7.00 p.m. SPINEWAY First-quarter 2025 revenue of €2.8 million In thousands of euros20252024Change as a %Q1 revenue2,8283,070-8% Unaudited consolidated... ► Artikel lesen | |
TEMPEST THERAPEUTICS | 7,050 | -100,00 % | Tempest Therapeutics: Tempest Receives Orphan Drug Designation from the FDA for TPST-1495 to Treat Patients with FAP | BRISBANE, Calif., April 21, 2025 (GLOBE NEWSWIRE) -- Tempest Therapeutics, Inc. (Nasdaq: TPST), a clinical-stage biotechnology company developing first-in-class1 targeted and immune-mediated therapeutics... ► Artikel lesen | |
PROCEPT BIOROBOTICS | 52,56 | 0,00 % | PROCEPT BioRobotics' Aquablation Therapy Spotlighted at 2025 AUA Annual Meeting Along with Expert-Led Workshops | ||
BRIGHTSPRING HEALTH SERVICES | 16,550 | +1,72 % | BrightSpring Health Services, Inc. Reports Fourth Quarter and Full Year 2024 Financial Results and Increases Full Year 2025 Guidance | LOUISVILLE, Ky., March 06, 2025 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. ("BrightSpring" or the "Company") (NASDAQ: BTSG), a leading provider of home and community-based health services... ► Artikel lesen | |
ALIGNMENT HEALTHCARE | 18,040 | 0,00 % | Alignment Healthcare Reports Fourth Quarter and Full-Year 2024 Results; Provides Full-Year 2025 Financial Guidance | Reports 189,100 health plan members as of Dec. 31, 2024, up 58.6% year-over-year, beating year-end expectationsAchieves first full year of positive adjusted EBITDA as a public company, driven by operating... ► Artikel lesen | |
LIFESTANCE HEALTH GROUP | 6,490 | 0,00 % | LifeStance Health Group, Inc.: LifeStance Reports Fourth Quarter and Full Year 2024 Results | SCOTTSDALE, Ariz., Feb. 27, 2025 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation's largest providers of outpatient mental healthcare, today announced financial... ► Artikel lesen | |
SIEMENS HEALTHINEERS | 46,440 | +1,22 % | EQS-DD: Siemens Healthineers AG: Darleen Caron, Kauf | Meldung und öffentliche Bekanntgabe der Geschäfte von Personen, die Führungsaufgaben wahrnehmen, sowie in enger Beziehung zu ihnen stehenden Personen
22.04.2025 / 17:45... ► Artikel lesen | |
FRESENIUS | 39,890 | +0,10 % | BARCLAYS stuft Fresenius SE auf 'Overweight' | LONDON (dpa-AFX Analyser) - Die britische Investmentbank Barclays hat das Kursziel für Fresenius von 44,00 auf 43,50 Euro gesenkt, aber die Einstufung auf "Overweight" belassen. Die Bad Homburger dürften... ► Artikel lesen | |
FRESENIUS MEDICAL CARE | 42,900 | +1,06 % | BARCLAYS stuft FMC FRESENIUS MEDICAL CARE AG & CO KGAA auf 'Equal Weight' | LONDON (dpa-AFX Analyser) - Die britische Investmentbank Barclays hat das Kursziel für FMC von 42,50 auf 40,50 Euro gesenkt, aber die Einstufung auf "Equal Weight" belassen. Die schwere Grippewelle... ► Artikel lesen | |
NUTEX HEALTH | 140,51 | 0,00 % | Nutex Health Inc. (NUTX): Among Most Expensive Stocks Insiders Are Buying After Trump's Tariff Rollout | ||
GENEDX | 109,22 | 0,00 % | GeneDx To Buy Fabric Genomics | ||
RXSIGHT | 14,730 | 0,00 % | RxSight, Inc. Announces Preliminary First Quarter 2025 Revenue and Revised 2025 Guidance | ALISO VIEJO, Calif., April 02, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) - RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following... ► Artikel lesen | |
GERRESHEIMER | 54,15 | +1,03 % | UBS stuft GERRESHEIMER AG auf 'Buy' | ZÜRICH (dpa-AFX Analyser) - Die Schweizer Großbank UBS hat das Kursziel für Gerresheimer von 106 auf 97 Euro gesenkt, aber die Einstufung auf "Buy" belassen. Der Jahresstart sei schwach gewesen, schrieb... ► Artikel lesen |